• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮克病中5-羟色胺能和胆碱能突触标志物的改变。

Altered serotonergic and cholinergic synaptic markers in Pick's disease.

作者信息

Sparks D L, Markesbery W R

机构信息

Alzheimer's Disease Research Center/Sanders-Brown Center on Aging, Department of Pathology, University of Kentucky Medical Center, Lexington 40536-0230.

出版信息

Arch Neurol. 1991 Aug;48(8):796-9. doi: 10.1001/archneur.1991.00530200032014.

DOI:10.1001/archneur.1991.00530200032014
PMID:1898253
Abstract

Choline acetyltransferase and acetylcholinesterase activities as well as serotonin and imipramine binding were determined in the hypothalamus, nucleus basalis of Meynert, and frontal and temporal poles of subjects with Pick's disease. Choline acetyltransferase activity was decreased in the hypothalamus and nucleus basalis of Meynert, and acetylcholinesterase activity was decreased in the nucleus basalis of Meynert only. Serotonin binding was decreased in all sites but the nucleus basalis of Meynert, and imipramine binding was altered only in the frontal pole. Comparison with previous reports of Alzheimer's disease indicates that with respect to these synaptic markers, Alzheimer's disease and Pick's disease are not similar.

摘要

在患有匹克氏病的受试者的下丘脑、迈内特基底核以及额叶和颞叶中,测定了胆碱乙酰转移酶和乙酰胆碱酯酶的活性以及血清素和丙咪嗪的结合情况。胆碱乙酰转移酶活性在下丘脑和迈内特基底核中降低,而乙酰胆碱酯酶活性仅在迈内特基底核中降低。血清素结合在除迈内特基底核之外的所有部位均降低,丙咪嗪结合仅在额叶中发生改变。与先前关于阿尔茨海默病的报告相比表明,就这些突触标记而言,阿尔茨海默病和匹克氏病并不相似。

相似文献

1
Altered serotonergic and cholinergic synaptic markers in Pick's disease.皮克病中5-羟色胺能和胆碱能突触标志物的改变。
Arch Neurol. 1991 Aug;48(8):796-9. doi: 10.1001/archneur.1991.00530200032014.
2
Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual.一名非痴呆个体中呈现皮克病特征的神经化学和组织病理学改变。
J Neuropathol Exp Neurol. 1994 Jan;53(1):37-42. doi: 10.1097/00005072-199401000-00005.
3
Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat.大鼠无名质和大细胞基底核中胆碱能神经元的5-羟色胺能输入。
Neuroscience. 1999;91(3):1129-42. doi: 10.1016/s0306-4522(98)00672-1.
4
Neurochemical observations in a case of Pick's disease.一例匹克氏病的神经化学观察
J Neurol Sci. 1980 Nov;48(2):257-63. doi: 10.1016/0022-510x(80)90205-1.
5
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.迈内特基底核(nbM)中的单胺能和胆碱能突触标记物:正常的年龄相关变化以及心脏病和阿尔茨海默病的影响
Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608.
6
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.阿尔茨海默病中的无名质:胆碱能标记酶的组织化学和生物化学研究
Neurosci Lett. 1982 Feb 12;28(2):217-22. doi: 10.1016/0304-3940(82)90155-0.
7
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.阿尔茨海默病与皮克病皮质胆碱能系统的尸检比较。
J Neurol Sci. 1983 Dec;62(1-3):211-7. doi: 10.1016/0022-510x(83)90200-9.
8
[Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
Nihon Rinsho. 1988 Jul;46(7):1491-5.
9
Dysfunction of the brain cholinergic system during aging and after lesions of the nucleus basalis of Meynert.
J Neural Transm Suppl. 1994;44:189-94. doi: 10.1007/978-3-7091-9350-1_14.
10
Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert.皮克病(叶性硬化症):迈内特基底核神经元缺失。
Neurology. 1983 Nov;33(11):1470-3. doi: 10.1212/wnl.33.11.1470.

引用本文的文献

1
Gut microbial metabolism in Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症的肠道微生物代谢。
Neurotherapeutics. 2024 Oct;21(6):e00470. doi: 10.1016/j.neurot.2024.e00470. Epub 2024 Oct 28.
2
Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia.额颞叶痴呆的神经精神症状的药物治疗。
CNS Drugs. 2021 Oct;35(10):1081-1096. doi: 10.1007/s40263-021-00854-5. Epub 2021 Aug 24.
3
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.痴呆症中的基底前脑胆碱能系统:脆弱性、弹性和抗性。
J Neurochem. 2021 Sep;158(6):1394-1411. doi: 10.1111/jnc.15471. Epub 2021 Aug 6.
4
FTLD Treatment: Current Practice and Future Possibilities.额颞叶痴呆的治疗:现状与未来可能。
Adv Exp Med Biol. 2021;1281:297-310. doi: 10.1007/978-3-030-51140-1_18.
5
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases.新型 PET 生物标志物可厘清与年龄相关的神经退行性疾病中的分子途径。
Cells. 2020 Dec 2;9(12):2581. doi: 10.3390/cells9122581.
6
A Clinical Guide to Frontotemporal Dementias.额颞叶痴呆临床指南
Focus (Am Psychiatr Publ). 2016 Oct;14(4):448-464. doi: 10.1176/appi.focus.20160018. Epub 2016 Oct 7.
7
Neurotransmitter deficits from frontotemporal lobar degeneration.来自额颞叶变性的神经递质缺失。
Brain. 2018 May 1;141(5):1263-1285. doi: 10.1093/brain/awx327.
8
Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.额颞叶及其他痴呆行为症状的非药物管理
Curr Neurol Neurosci Rep. 2016 Feb;16(2):14. doi: 10.1007/s11910-015-0618-1.
9
Improving response inhibition systems in frontotemporal dementia with citalopram.使用西酞普兰改善额颞叶痴呆的反应抑制系统。
Brain. 2015 Jul;138(Pt 7):1961-75. doi: 10.1093/brain/awv133. Epub 2015 May 21.
10
Is synaptic loss a unique hallmark of Alzheimer's disease?突触丧失是阿尔茨海默病的独特特征吗?
Biochem Pharmacol. 2014 Apr 15;88(4):517-28. doi: 10.1016/j.bcp.2013.12.028. Epub 2014 Jan 9.